Receive news by e-mail

#
 

Enter your e-mail in the field below to receive directly the news that appears on this page.

 

topics : related - all Explore

Shopping Categories

  1. 1. Cell Phones
  2. 2. Smartphones
  3. 3. Digital Cameras
  4. 4. Laptop Computers
  5. 5. Processors
  6. 6. Motherboards
  7. 7. LCD Monitors
  8. 8. Graphics Cards
  9. 9. GPS
  10. 10. Digital Camcorders
  11. 11. Printers
  12. 12. Desktop Computers
  13. 13. Sedans
  14. 14. Coupes & Convertibles
  15. 15. 4x4

Wikio Shopping

  1. 1. Automotive
  2. 2. Beauty & Fragrances
  3. 3. Books
  4. 4. Car/Motorbike
  5. 5. CD
  6. 6. Clothing, Accessories & Shoes
  7. 7. Communication
  8. 8. Computers
  9. 9. DVD
  10. 10. Electronics
  11. 11. Flowers & Gifts
  12. 12. Gourmet & Foods
  13. 13. Health & Personal Care
  14. 14. Home & Garden
  15. 15. Hotels
  16. 16. Household Appliances
  17. 17. Jewelry & Watches
  18. 18. Musical Instruments
  19. 19. Sports & Outdoors
  20. 20. Toys & Baby
  21. 21. Video Games

Participate



Mylan Inc.



Sort by : relevance - date - popularity
5Vote!

Audit Integrity Corrects and Upgrades Mylan Inc’s Bankruptcy Probability Ranking after Correcting for Thomson Reuters’ Stock Pricing Error

LOS ANGELES--(BUSINESS WIRE)--Audit Integrity, an independent financial research and risk modeling firm, announced today that it has revised and upgraded Mylan Inc’s bankruptcy probability ranking. Due to a stock pricing error made by data provider Thomson Reuters, Mylan was erroneously placed among the companies most likely to go bankrupt over the next twelve months. Audit Integrity’s...

3Vote!

Feds find no problems at Mylan's Morgantown plant

Federal authorities found no problems at Mylan Inc’s Morgantown W.Va. plant during an inspection last month, Food and Drug Administration spokeswoman Judy Leon said Thursday.

4Vote!

FDA Probe of Mylan Inc. Completed

The final report found no deficiencies.

3Vote!

Mylan Receives FDA Approval For Generic Version Of Migraine Treatment Imitrex(R)

Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg (base), 50 mg (base) and 100 mg (base). This product is manufactured in Mylan's Morgantown, W.Va. facility. Mylan Chairman and CEO Robert J.

5Vote!

Lowering HIV Drug Cost In Poor Nations

An arrangement between former President Bill Clinton's foundation and two drug corporations will decrease prices on medicines for patients with drug-defiant HIV in developing countries.One contract, with Mylan Inc., drops the yearly cost of four antiretroviral drugs that are a second kind of treatment when patients build up a resistance to the drugs that are initially used.The other arrangement, with...

3Vote!

Clinton deal lowers HIV drug cost in poor nations

NEW YORK - Former President Bill Clinton has struck an agreement with two drug companies to provide cheaper, better HIV treatments to patients in poor nations. The deal involves antiretroviral medications made by Pfizer Inc. and Mylan Inc. Clinton s ...

5Vote!

Clinton deal lowers HIV drug cost in poor nations

Former President Bill Clinton has struck an agreement with two drug companies to provide cheaper, better HIV treatments to patients in poor nations. The deal involves antiretroviral medications made by Pfizer Inc. and Mylan Inc. Clinton says the arrangement... Sponsored Topics: Bill Clinton - HIV - Antiretroviral drug - United States - Health

3Vote!

Daiichi wins patent battle

TOKYO: Japanese drug major Daiichi Sankyo said on Monday a U.S. Court has ruled in its favour in a patent litigation related to the anti-hypertensive drug, Benicar, against Mylan Inc and its Indian subsidiary, Matrix ...

5Vote!

Mylan leads drug stock higher

BOSTON (MarketWatch) -- Mylan Inc. led drug stocks into positive territory as shares of the generic drugmaker gained on a positive second-quarter earnings report. The NYSE Arca Pharmaceutical Index climbed 0.8% to 281.75 and the NYSE Arca Biotechnology Index edged up 0.4% to 887.82. The Dow Jones Industrial Average advanced 70 points to 9,137. Shares of Mylan were up 4% at $13.40. Market Pulse Stories...

5Vote!

Mylan posts 2Q profit

Generic drug giant Mylan Inc. on Thursday reported net income of $58 million or 19 cents per share, on revenue of $1.25 billion, for the quarter ended June 30.

4Vote!

Mylan swings to profit, raises guidance

LONDON (MarketWatch) -- Mylan Inc. swung to a second quarter profit of 19 cents a share vs. a loss of 5 cents a share a year earlier. The company raised its full-year adjusted diluted earnings guidance to a range of $1.13 to $1.20 a share. Adjusted diluted earnings, which exclude one-time items, rose to 32 cents a share in the second quarter. Market Pulse Stories are Rapid-fire, short news bursts...

5Vote!

Heather Bresch named president of Mylan

Heather Bresch has been promoted to president of generic drug giant Mylan Inc. and Rajiv Malik was named to fill Bresch’s previous role as chief operating officer, the Canonsburg-based company announced Wednesday. (MYL)

5Vote!

Mylan names Heather Bresch president

Pharmaceutical company Mylan Inc. says it promoted chief operating officer Heather Bresch to the post of president.

4Vote!

Mylan names Heather Bresch president

Pharmaceutical company Mylan Inc. says it promoted chief operating officer Heather Bresch to the post of president.

5Vote!

EDITORIAL - Adverse reaction: The FDA probes quality control at Mylan

When an internal report shows that the world's third largest generic drug maker routinely violated standard operating procedures, a lot of people should be concerned -- not just its employees and stockholders. That's why prescription drug consumers and the general public should welcome the Food and Drug Administration's investigation of Mylan Inc. for possible violation of government-mandated quality...